Markets:

Overview

News

Currencies

International

Treasuries

Polyrizon Ltd. - Ordinary Shares (NQ:PLRZ)

11.59 +0.10 (+0.87%)

Streaming Delayed Price Updated: 12:40 PM EDT, Aug 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Polyrizon Ltd. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

Top movers in Tuesday's after hours session ↗

March 25, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 25, 2025

Via Benzinga

Polyrizon Expands Drug Delivery Innovation with Preclinical Studies for Epilepsy Rescue Treatment

March 25, 2025

From Polyrizon Ltd.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 24, 2025

Via Benzinga

Clearmind to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination

March 19, 2025

From Clearmind Medicine Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 14, 2025

Via Benzinga

Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments

March 14, 2025

From Polyrizon Ltd.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 13, 2025

Via Benzinga

Polyrizon Launches Preclinical Studies for Intranasal Naloxone to Combat Opioid Overdose Using Cutting-Edge Platform

March 13, 2025

From Polyrizon Ltd.

Via GlobeNewswire

Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024

March 11, 2025

From Polyrizon Ltd.

Via GlobeNewswire

Polyrizon Initiates Preclinical Studies for Intranasal Naloxone Targeting Opioid Overdose Based on Its Innovative T&T Platform

March 10, 2025

From Polyrizon Ltd.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

January 30, 2025

Via Benzinga

Polyrizon Announces Filing of Divisional Patent Application for Its Innovative Trap & Target™ (T&T) Intranasal Drug Delivery Platform

January 30, 2025

From Polyrizon Ltd.

Via GlobeNewswire

Polyrizon Commences GMP Manufacturing Preliminary Process for its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

January 23, 2025

From Polyrizon Ltd.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 31, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 30, 2024

Via Benzinga

Why Is Development-Stage Biotech Company Polyrizon Stock Surging Today? ↗

December 30, 2024

Polyrizon shares rise after disclosing the publication of a national phase patent application for nasal protection and drug delivery technologies.

Via Benzinga

Topics Intellectual Property

Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies

December 30, 2024

From Polyrizon Ltd.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 19, 2024

Via Benzinga

Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs

December 19, 2024

From Polyrizon Ltd.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 18, 2024

Via Benzinga

Crude Oil Gains Over 1%, General Mills Shares Fall ↗

December 18, 2024

Via Benzinga

What's Going On With Polyrizon Shares Wednesday? ↗

December 18, 2024

Polyrizon shares are moving higher after the company announced it secured a manufacturing agreement with Eurofins CDMO Amatsiaquitaine.

Via Benzinga

Dow Surges 150 Points, US Current Account Deficit Widens In Q3 ↗

December 18, 2024

Via Benzinga

Topics Stocks

Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker

December 18, 2024

From Polyrizon Ltd.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 17, 2024

Via Benzinga

Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance

December 13, 2024

From Polyrizon Ltd.

Via GlobeNewswire

Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial

December 02, 2024

From Polyrizon Ltd.

Via GlobeNewswire

Heritage Distilling, Dynamix Open For Trading ↗

November 24, 2024

Heritage Distilling, Ming Shing, and Dynamix all made a public debut as the IPO market has cooled off ahead of Thanksgiving week in the U.S.

Via Talk Markets

Topics Initial Public Offering Stocks / Equities

BioMedNewsBreaks — Polyrizon Ltd. (NASDAQ: PLRZ) Secures $4.2M in Initial Public Offering

October 30, 2024

Via Investor Brand Network

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.